The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 12, Issue 10, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-10-15
DOI
10.1038/s41419-021-04248-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Nintedanib in an Animal Model of Liver Fibrosis
- (2020) Lutz Wollin et al. Biomed Research International
- Epithelial Vasopressin Type-2 Receptors Regulate Myofibroblasts by a YAP-CCN2–Dependent Mechanism in Polycystic Kidney Disease
- (2020) Nidhi Dwivedi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Quantification of Lung Fibrosis in IPF-Like Mouse Model and Pharmacological Response to Treatment by Micro-Computed Tomography
- (2020) Francesca Ruscitti et al. Frontiers in Pharmacology
- Glycogen synthase kinase‐3β inhibits tubular regeneration in acute kidney injury by a FoxM1‐dependent mechanism
- (2020) Sonali Sinha et al. FASEB JOURNAL
- Nintedanib promotes antitumour immunity and shows antitumour activity in combination with PD-1 blockade in mice: potential role of cancer-associated fibroblasts
- (2020) Ryoji Kato et al. BRITISH JOURNAL OF CANCER
- The Controversial Role of Fibrosis in Autosomal Dominant Polycystic Kidney Disease
- (2020) Maria Fragiadaki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Autosomal dominant polycystic kidney disease: Disrupted pathways and potential therapeutic interventions
- (2019) Talieh Malekshahabi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- A gain-of-functional screen identifies the Hippo pathway as a central mediator of receptor tyrosine kinases during tumorigenesis
- (2019) Taha Azad et al. ONCOGENE
- Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy
- (2019) Sonali Sinha et al. ONCOGENE
- A RhoA–YAP–c-Myc signaling axis promotes the development of polycystic kidney disease
- (2018) Jing Cai et al. GENES & DEVELOPMENT
- CD8+ T cells modulate autosomal dominant polycystic kidney disease progression
- (2018) Emily K. Kleczko et al. KIDNEY INTERNATIONAL
- Receptor Tyrosine Kinase-Targeted Cancer Therapy
- (2018) Toshimitsu Yamaoka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy
- (2016) Mahdi Shabani et al. CURRENT DRUG TARGETS
- Receptor Tyrosine Kinase Phosphorylation Pattern-Based Multidrug Combination Is an Effective Approach for Personalized Cancer Treatment
- (2016) X. Sun et al. MOLECULAR CANCER THERAPEUTICS
- A cAMP and CREB-mediated feed-forward mechanism regulates GSK3βin polycystic kidney disease
- (2016) Vijayakumar R. Kakade et al. Journal of Molecular Cell Biology
- Nintedanib Is a Highly Effective Therapeutic for Neuroendocrine Carcinoma of the Pancreas (PNET) in the Rip1Tag2 Transgenic Mouse Model
- (2015) R. Bill et al. CLINICAL CANCER RESEARCH
- Nintedanib: From Discovery to the Clinic
- (2015) Gerald J. Roth et al. JOURNAL OF MEDICINAL CHEMISTRY
- Glycogen synthase kinase-3β promotes cyst expansion in polycystic kidney disease
- (2015) Shixin Tao et al. KIDNEY INTERNATIONAL
- Nintedanib: A Novel Therapeutic Approach for Idiopathic Pulmonary Fibrosis
- (2014) I. A. Dimitroulis Respiratory Care
- Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity
- (2012) Katharina Hopp et al. JOURNAL OF CLINICAL INVESTIGATION
- Fibrosis and progression of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- (2011) Jill Norman BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Macrophages Promote Cyst Growth in Polycystic Kidney Disease
- (2011) A. Karihaloo et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Why kidneys fail in autosomal dominant polycystic kidney disease
- (2011) Jared J. Grantham et al. Nature Reviews Nephrology
- Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
- (2011) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- ERK1/2-Dependent Vascular Endothelial Growth Factor Signaling Sustains Cyst Growth in Polycystin-2 Defective Mice
- (2009) Carlo Spirli et al. GASTROENTEROLOGY
- Src Inhibition Ameliorates Polycystic Kidney Disease
- (2008) W. E. Sweeney et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Influence of VEGF Polymorphism on Progression of Autosomal Dominant Polycystic Kidney Disease
- (2008) J. Reiterová et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Autosomal Dominant Polycystic Kidney Disease
- (2008) Jared J. Grantham NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started